loading

Immix Biopharma Inc (IMMX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
3.99%
5.5901
5.3759 4.5238 3.7207 2.5208
Operating Income/Loss
3.99%
-5.5901
-5.3759 -4.5238 -3.7207 -2.5208
Nonoperating Income/Loss
0.2679
- - 0.1288 0.0279
Income/Loss From Continuing Operations Before Tax
3.40%
-5.3222
-5.1473 -4.3371 -3.5919 -2.4929
Income Tax Expense/Benefit
9.27%
0.00884
0.00809 0.00681 0.00635 0.00517
Income/Loss From Continuing Operations After Tax
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Net Income/Loss
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
9.43%
-0.0721
-0.0659 -0.0632 - -
Basic Average Shares
1,484%
23.44
1.48 18.58 15.04 13.90
Diluted Average Shares
1,484%
23.44
1.48 18.58 15.04 -0.5706
Basic Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Diluted Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):